Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
French healthcare giant Sanofi is the last buyer still in the running to acquire German Bayer’s blood glucose management devices, a deal that may be worth more than $1.5 billion, sources say.
As medtech industry groups continue to rally for repeal of the 2.3% tax set to hit in January, law makers are calling for a delay in the tax’s implementation.
Russian "cyber criminals" are demanding a $4,000 ransom to decode a hijacked medical center server housing sensitive patient information.